ストックスクリーナーアプリを入手
6.80
2.30%
-0.16
アフターアワーズ：
6.70
-0.10
-1.47%
Nuvectis Pharma Inc (NVCT) 最新ニュース
How to read the order book for Nuvectis Pharma Inc.Pattern Breakout Prediction for Short Term - Newser
Will Nuvectis Pharma Inc. benefit from macro trendsDaily Exit and Entry Price Prediction - Newser
Key resistance and support levels for Nuvectis Pharma Inc.Pattern Recognition Tool for ROI Investors - Newser
Using R and stats models for Nuvectis Pharma Inc. forecastingPattern Recognition Tool for ROI Investors - Newser
Nuvectis Pharma Provides Final Clinical Data Update from - GlobeNewswire
Prime Medicine is selling $125M in stock; Nuvectis stops work on ovarian cancer drug - Endpoints News
Is Nuvectis Pharma Inc. a growth stock or a value stockExpert Picks Review With Low Risk - jammulinksnews.com
Nuvectis Pharma Plunges 15.1% on NXP800 Halt - AInvest
Nuvectis halts NXP800 development for ovarian cancer, shifts focus By Investing.com - Investing.com Nigeria
Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study - GlobeNewswire
Is it time to cut losses on Nuvectis Pharma Inc.Earnings Report Summary with Market Impact - Newser
What makes Nuvectis Pharma Inc. stock price move sharplyInvestment Position Summary with Timeframe Forecast - Newser
Exit strategy if you’re trapped in Nuvectis Pharma Inc.Asset Safety Selection Using Quantitative Analysis - Newser
Why Nuvectis Pharma Inc. stock attracts strong analyst attentionSmart Risk Strategy with Entry Optimization - Newser
Real time scanner hits for Nuvectis Pharma Inc. explainedFree Quick Gain Stock Watch With Indicators - Newser
Volume spikes in Nuvectis Pharma Inc. stock – what they meanFree Weekly Stock Watch With Growth Focus - Newser
Nuvectis Pharma Inc. Volume Confirms Breakout — Analysts BullishTrade Setups With Clear Risk Limits Highlighted - metal.it
Published on: 2025-07-29 06:16:31 - Newser
How strong is Nuvectis Pharma Inc. company’s balance sheetStock Market Picks With High Returns - jammulinksnews.com
Why is Nuvectis Pharma Inc. stock attracting strong analyst attentionMarket-beating performance - jammulinksnews.com
Exit strategy if you’re trapped in Nuvectis Pharma Inc. Stable Profit Zone and Loss Control Analysis - Newser
Real time scanner hits for Nuvectis Pharma Inc. explained Top Stock Picks with Forecast Accuracy - Newser
What institutional investors are buying Nuvectis Pharma Inc. stockEarnings Report Ideas With High Returns - jammulinksnews.com
Does Nuvectis Pharma Inc. stock perform well during market downturnsGrow your portfolio with growth-oriented stocks - jammulinksnews.com
What is Nuvectis Pharma Inc. company’s growth strategyCapitalize on market trends with confidence - jammulinksnews.com
What is the dividend policy of Nuvectis Pharma Inc. stockExplosive earnings growth - jammulinksnews.com
When is Nuvectis Pharma Inc. stock expected to show significant growthPowerful market insights - jammulinksnews.com
Published on: 2025-07-28 00:51:34 - jammulinksnews.com
Nuvectis Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingChart Breakout Alert - Newser
Why Nuvectis Pharma Inc. stock is on top investor watchlistsSkyrocketing investment returns - jammulinksnews.com
Nuvectis Pharma Inc. Stock Analysis and ForecastSuperior returns - Autocar Professional
What drives Nuvectis Pharma Inc. stock priceRecord-breaking capital gains - Autocar Professional
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):